These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 785426)

  • 41. Efficacy and safety of 1 and 2 doses of live attenuated influenza vaccine in vaccine-naive children.
    Bracco Neto H; Farhat CK; Tregnaghi MW; Madhi SA; Razmpour A; Palladino G; Small MG; Gruber WC; Forrest BD;
    Pediatr Infect Dis J; 2009 May; 28(5):365-71. PubMed ID: 19395948
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Results of a study of the effectiveness of simultaneous immunization against influenza with live and inactivated vaccines (1980-1983)].
    Zhilova GP; Ignat'eva GS; Orlov VA; Malikova EV; Maksakova VL
    Vopr Virusol; 1986; 31(1):40-4. PubMed ID: 2938336
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Protective efficacy of a live, attenuated, influenza virus vaccine ('Alice' strain).
    Prinzie A; Delem A; Huygelen C
    Postgrad Med J; 1976 Jun; 52(608):395-8. PubMed ID: 785431
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Methodological approach to evaluating the vaccinal prevention of influenza as an epidemic control measure].
    Rykushin IuP; Mukhina LP
    Tr Inst Im Pastera; 1982; 59():55-9. PubMed ID: 6228045
    [No Abstract]   [Full Text] [Related]  

  • 45. [Influenza vaccination. The importance of antigen amount and adjuvant with reference to the humoral antibody formation after influenza vaccination. A comparative double-blind study with various vaccines].
    Sarateanu DE; Ehrengut W
    Fortschr Med; 1981 Sep; 99(34):1348-52. PubMed ID: 7026399
    [No Abstract]   [Full Text] [Related]  

  • 46. The role of nasal IgA in children vaccinated with live attenuated influenza vaccine.
    Ambrose CS; Wu X; Jones T; Mallory RM
    Vaccine; 2012 Nov; 30(48):6794-801. PubMed ID: 23000125
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Effectiveness of inactivated vaccines against influenza].
    Fridman EA; Peradze TV
    Tr Inst Im Pastera; 1982; 58():84-94. PubMed ID: 6764983
    [No Abstract]   [Full Text] [Related]  

  • 48. Prevention and treatment of influenza infections.
    Iacuzio D
    Adv Intern Med; 2001; 46():51-76. PubMed ID: 11147260
    [No Abstract]   [Full Text] [Related]  

  • 49. Efficacy of inactivated split-virus influenza vaccine against culture-confirmed influenza in healthy adults: a prospective, randomized, placebo-controlled trial.
    Beran J; Vesikari T; Wertzova V; Karvonen A; Honegr K; Lindblad N; Van Belle P; Peeters M; Innis BL; Devaster JM
    J Infect Dis; 2009 Dec; 200(12):1861-9. PubMed ID: 19909082
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Comparative efficacy of influenza vaccines.
    Narayan KM; del Rio C
    N Engl J Med; 2010 Jan; 362(2):179-80; author reply 180-1. PubMed ID: 20071712
    [No Abstract]   [Full Text] [Related]  

  • 51. Comparative efficacy of influenza vaccines.
    Linder J
    N Engl J Med; 2010 Jan; 362(2):180; author reply 180-1. PubMed ID: 20077593
    [No Abstract]   [Full Text] [Related]  

  • 52. A systematic review of the efficacy of live attenuated influenza vaccine upon revaccination of children.
    Caspard H; Heikkinen T; Belshe RB; Ambrose CS
    Hum Vaccin Immunother; 2016 Jul; 12(7):1721-7. PubMed ID: 26751513
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Report of the 7th meeting on Evaluation of Pandemic Influenza Vaccines in Clinical Trials, World Health Organization, Geneva, 17-18 February 2011.
    Girard MP; Katz JM; Pervikov Y; Hombach J; Tam JS
    Vaccine; 2011 Oct; 29(44):7579-86. PubMed ID: 21856358
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Clinical trials with intranasally administered WRL 105 strain live influenza vaccine in volunteers.
    Freestone DS
    Dev Biol Stand; 1976; 33():207-12. PubMed ID: 782971
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Vaccinal prevention of influenza in children].
    Zykov MP; Vasil'eva RI
    Tr Inst Im Pastera; 1982; 58():30-8. PubMed ID: 6764981
    [No Abstract]   [Full Text] [Related]  

  • 56. Immunogenicity and efficacy of the monovalent, trivalent and quadrivalent intranasal live attenuated influenza vaccines containing different pdmH1N1 strains.
    Yeolekar LR; Ganguly M; Tyagi P; Ingle NB; Stittelaar KJ; Waal L; Scorza FB; Mahmood K; Dhere RM
    Vaccine; 2018 Nov; 36(46):6944-6952. PubMed ID: 30322745
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Pandemic preparedness with live attenuated influenza vaccines based on A/Leningrad/134/17/57 master donor virus.
    Rudenko L; Isakova-Sivak I
    Expert Rev Vaccines; 2015 Mar; 14(3):395-412. PubMed ID: 25555687
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Genetic stability of live attenuated vaccines against potentially pandemic influenza viruses.
    Kiseleva I; Dubrovina I; Fedorova E; Larionova N; Isakova-Sivak I; Bazhenova E; Pisareva M; Kuznetsova V; Flores J; Rudenko L
    Vaccine; 2015 Dec; 33(49):7008-14. PubMed ID: 26432909
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Immunization against influenza: comparison of various topical and parenteral regimens containing inactivated and/or live attenuated vaccines in healthy adults.
    Keitel WA; Cate TR; Nino D; Huggins LL; Six HR; Quarles JM; Couch RB
    J Infect Dis; 2001 Jan; 183(2):329-332. PubMed ID: 11110645
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Inactivated influenza virus vaccines in children.
    Ruben FL
    Clin Infect Dis; 2004 Mar; 38(5):678-88. PubMed ID: 14986252
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.